为您找到相关结果约500个

你是不是要搜索 期刊对IIIA期（N2）非鳞状非小细胞肺癌患者进行培美曲塞-顺铂联合贝伐单抗或同步胸部放疗后手术的II期随机试验 点击跳转

ZDP(n) ${Z}_{DP}(n)$ is bounded above by n2-(n+3)/2 ${n}∧{2}-(n+3)\unicode{x02215}2$

Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients

Occult stage IIIA-N2 patients have excellent overall survival with initial surgery

Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

S-1+Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous CellCarcinoma: Results of a Phase II Trial

Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer

Postoperative radiotherapy in non-small cell lung cancer stage IIIA-N2: Focus and perspectives

Treatment of stage IIIA-N2 EGFR-mutant non-smallcell lung adenocarcinoma

Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study

Weekly nab-paclitaxel plus carboplatin as neoadjuvant therapy for IIIA-N2 lung squamous cell carcinoma: A prospective phase II study.

Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study

Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study

Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant

为您找到相关结果约500个

共500条页码: 1/34页15条/页